IL6 and cardiac arrhythmia: The continued use of selective inhibitors of IL-6 trans-signaling together with global IL-6 inhibitors is likely to improve our current understanding of IL-6 signaling, with implications for improved and effective therapeutic interventions in patients with acquired inflammatory diseases and arrhythmias.